Oncology needs talent
Pharma’s traditional R&D path is a business model under pressure. The ever-increasing demand for talented leadership in oncology is driving a need for collaboration
Search Results for: Nick Stephens and Dr Andy Theodorou
- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
- Study finds mechanical changes in tumour tissue offer new insights for cancer research
- Cambridge study finds AI more accurately assesses eye problems compared to doctors
